Who is sponsoring NCT03908710?

NCT03908710 is sponsored by Accumbo AB.

What drugs are being tested in NCT03908710?

Interventions in NCT03908710: Treatment of hypertension using blood pressure self-measurement at home.

What condition does NCT03908710 study?

NCT03908710 studies Hypertension,Essential.

Is NCT03908710 still recruiting?

NCT03908710 is currently completed. Last updated 11 April 2019.

Last reviewed 2019-04-11 · How we verify

NCT03908710

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The Accumbo Home Blood Pressure Trial

Completed NA Last updated 11 April 2019

What this trial tests

NA trial testing Treatment of hypertension using blood pressure self-measurement at home in Hypertension,Essential in 172 participants. Completed in 30 October 2018.

Timeline

1 June 2018

Primary endpoint
30 October 2018

30 October 2018

Quick facts

Lead sponsor	Accumbo AB
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	non randomized
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	172
Start date	1 June 2018
Primary completion	30 October 2018
Estimated completion	30 October 2018
Sites	1 location across Sweden

Drugs / interventions tested

Treatment of hypertension using blood pressure self-measurement at home

Conditions studied

Hypertension,Essential — all drugs for Hypertension,Essential →

Sponsor

Accumbo AB

Who can join

Adults 35 to 70, any sex, with Hypertension,Essential. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Aim of the study was to investigate a new clinical medical system for treatment of hypertension with a clinical decision system,a smartphone patient app and a home blood pressure monitor.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Hypertension,Essential

Currently open trials in the same condition.

NCT05067998 — The Benefits of Natural Medicine, Vitamin IV Therapy and Supplements: Maintaining Good Health Through Nature · recruiting
NCT06461273 — Food is Medicine vs Lifestyle Medicine For Cardiovascular Kidney Metabolic (CKM) Syndrome · NA · active not recruiting
NCT06205628 — Safety, Tolerability, PK and PD of ADX-850 in Participants With Hypertension · Phase 1 · active not recruiting
NCT04505618 — Optical Coherence Tomography Angiography in Subjects With Retinal Vascular Disease · NA · recruiting
NCT04625569 — Genetic of Response to Acute Saline Load Test in Hypertension (Naload) · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03908710 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Accumbo AB
Last refreshed: 11 April 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03908710.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing